Here are a few important points to consider: The recent contest results don’t spell doom for AI in biotech. Instead, they highlight the need for a more nuanced understanding of AI’s ...

Artificial intelligence (AI) is revolutionizing biotechnology, enabling groundbreaking innovations across a wide range of applications. Recent developments, such as the $80 million funding round ...

Positive expectations for biotech AI success should be tempered. AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Be wary that ...

Opinions expressed by Digital Journal contributors are their own. Integrated AI and biotechnology are some of the most promising trends that have emerged recently. With the rise of computational ...

The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and ...

Longevity biotechnology seeks to change this by combining AI with biomarker analysis to detect early signs of aging, enabling targeted interventions that not only delay disease but also promote ...

The AI biotech is also looking to expand its team as it grows. "This funding will further turbocharge the development of our next-generation AI drug design engine, help us advance our own programs ...

AI-driven systems offer smarter exploration and operation methods, while biotechnology solutions are being used to reduce toxic waste and enhance the ecological footprint of mining.

Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits he doesn’t know the first thing about ...